Clinical Trials Logo

Clinical Trial Summary

This clinical investigation is being undertaken to examine the performance of the CE marked Proxima System - a patient attached blood gas analyser.

The study forms an element of the Post Market surveillance plan for the Proxima system and will also generate method comparison data to allow Sphere Medical to submit the Proxima for FDA regulatory clearance.


Clinical Trial Description

The PROX006 study is an open and non-randomised study that will be conducted to assess the performance of the Proxima (a CE marked Medical Device)on a wide range of patients with a variety of conditions. This study will allow the performance of the Proxima and the institution's conventional blood gas analyser to be compared when used in the Intensive Care Unit and Operating Theatre.

The PROX006 investigation is an observational method comparison study - the results obtained from the Proxima will be compared with those obtained on the institution's conventional blood gas analyser (BGA). The potential for bias by the user will be negated in this study by directly comparing the results from the BGA and Proxima.

The data/results documented in the Case Report Form (CRF) will be verified during monitoring visits. ;


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01921023
Study type Observational
Source Sphere Medical Ltd.
Contact
Status Completed
Phase N/A
Start date September 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT03242525 - Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis
Completed NCT01423942 - Maturation of the Autonomic Nervous System in Prematures N/A
Completed NCT02919657 - Absorption Comparison on Equivalency Value of Genepro Gen2 Phase 4
Completed NCT02838654 - Cervical Epidural Waveform Analysis Using Pressure Monitoring Kit N/A
Completed NCT03245294 - Factors Contributing to the Pressure Wave Form Changes N/A